- Home
- About Us
- Service
- Application
- Technology
- Contact Us
HapOnco® Hereditary Cancer GeneTesting
HapOnco® Hereditary Cancer GeneTesting
HapOnco<sup>®</sup> Hereditary Cancer Gene Testing
Product Introduction
Hereditary cancer refers to a category of tumors that have heritable characteristics, accounting for 5 - 10% of all tumors. When an individual carries a mutated gene, the risk of developing cancer is significantly increased. If cancer is detected early and timely prevention and treatment are carried out, a better prognosis can be achieved. HaploX independently developed the HapOnco® Hereditary Cancer Gene Testing product, which can detect genes related to the heritability of tumors and provide guidance for clinical diagnosis and the development of treatment plans.
Product Content
| Testing Content | Number of Genes | Applicable Cancer Types |
|---|---|---|
| Hereditary Comprehensive Cancer Gene Testing | 89 full exonic regions | 33 hereditary cancer syndromes |
| Hereditary Breast and Gynecological Cancer Gene Testing | 30 full exonic regions | Breast cancer, ovarian cancer, endometrial cancer, and related gynecological cancer syndromes |
| Hereditary Colorectal Cancer 26 Gene Testing | 26 full exonic regions | Colorectal cancer syndromes |
Hereditary Cancer Comprehensive Panel: advanced screening for the 33 Hereditary Cancers, empowers individuals to understand their risk and take control of their health.
| Colorectal Cancer | Small Intestine Cancer | Breast Cancer | Ovarian Cancer | Endometrial Cancer | Gastric Cancer |
| Gastrointestinal Stromal Tumor (GIST) | Esophageal Cancer | Bile Duct Cancer | Pancreatic Cancer | Renal Cancer | Urothelial Cancer |
| Bladder Cancer | Prostate Cancer | Thyroid Cancer | Parathyroid Cancer | Melanoma | Basal Cell Carcinoma |
| Pituitary Tumor | Schwannoma | Soft Tissue Sarcoma | Neuroblastoma | Retinoblastoma | Pheochromocytoma |
| Paraganglioma | Multiple Osteochondromas | Multiple Endocrine Neoplasia (MEN) | Neurofibromatosis | Cardiac and Ovarian Fibroma | Pleuropulmonary Blastoma |
| Central Nervous System Tumor | Bloom Syndrome | Lynch Syndrome |
Applicable Population
Patients with hereditary cancer and their relatives; people with direct relatives suffering from hereditary cancer or with a family history of hereditary cancer; families with multiple cancer cases; individuals carrying cancer susceptibility genes.
Address
Units 610, 6/F, Building 16W, Phase 3, HongKong Science Park, New Territories, HongKong
Phone
+852 69410851
customer_service@haplox.net
© 2025 HaploX Ltd. All Rights Reserved.
